<<<<<<< HEAD
<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>Microsoft Word - B.Pharm VI Sem _Syllabus_ as per PCI Regulation</title><meta name="author" content="hp"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 h1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; margin:0pt; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 12pt; }
 h2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 11.5pt; }
 .s4 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10.5pt; vertical-align: -2pt; }
 .s5 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .s6 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10.5pt; vertical-align: 7pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 2; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, upper-roman)" "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 li {display: block; }
 #l2 {padding-left: 0pt;counter-reset: d1 1; }
 #l2> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: e1 1; }
 #l3> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: e1 0;  }
</style></head><body><h1 style="padding-top: 3pt;padding-left: 85pt;text-indent: 0pt;text-align: center;">PY-601 . MEDICINAL CHEMISTRY – III (Theory)</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: justify;">Study of the development of the following classes of drugs, Classification, mechanism of action, uses of drugs mentioned in the course, Structure activity relationship of selective class of drugs as specified in the course and synthesis of drugs superscripted by (*)</p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – I</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Antibiotics</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Historical background, Nomenclature, Stereochemistry, Structure activity relationship, Chemical degradation classification and important products of the following classes :</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">β-Lactam antibiotics: <span class="p">Penicillin, Cepholosporins, β- Lactamase inhibitors, Monobactams</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Aminoglycosides: <span class="p">Streptomycin, Neomycin, Kanamycin</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Tetracyclines: <span class="p">Tetracycline,Oxytetracycline, Chlortetracycline, Minocycline, Doxycycline</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – II</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Antibiotics</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Historical background, Nomenclature, Stereochemistry, Structure activity relationship, Chemical degradation classification and important products of the following classes: <b>Macrolide: </b>Erythromycin Clarithromycin, Azithromycin.</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Miscellaneous: <span class="p">Chloramphenicol*, Clindamycin.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Prodrugs: <span class="p">Basic concepts and application of prodrugs design.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Antimalarials: <span class="p">Etiology of malaria.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Quinolines: <span class="p">SAR, Quinine sulphate, Chloroquine*, Amodiaquine, Primaquine phosphate, Pamaquine*, Quinacrine hydrochloride, Mefloquine.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Biguanides and dihydro triazines: <span class="p">Cycloguanil pamoate, Proguanil.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Miscellaneous: <span class="p">Pyrimethamine, Artesunete, Artemether, Atovoquone.</span></h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – III</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Anti-tubercular Agents</h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Synthetic anti tubercular agents: <span class="p">Isoniozid*, Ethionamide, Ethambutol, Pyrazinamide, Para amino salicylic acid.*</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Anti tubercular antibiotics: <span class="p">Rifampicin, Rifabutin, Cycloserine Streptomycine, Capreomycin sulphate.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Urinary tract anti-infective agents</h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Quinolones:<span class="p">SAR     of   quinolones,   Nalidixic Acid,Norfloxacin, </span><span class="s1">Enoxacin,</span></h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Ciprofloxacin*, Ofloxacin, Lomefloxacin, Sparfloxacin, Gatifloxacin, Moxifloxacin</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Miscellaneous: Furazolidine, Nitrofurantoin*, Methanamine.</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Antiviral agents:</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Amantadine hydrochloride, Rimantadine hydrochloride, Idoxuridine trifluoride, Acyclovir*, Gancyclovir, Zidovudine, Didanosine, Zalcitabine, Lamivudine, Loviride, Delavirding, Ribavirin, Saquinavir, Indinavir, Ritonavir.</p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – IV</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Antifungal agents:</h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Antifungal antibiotics: <span class="p">Amphotericin-B, Nystatin, Natamycin, Griseofulvin.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Synthetic Antifungal agents: <span class="p">Clotrimazole, Econazole, Butoconazole, Oxiconazole Tioconozole,  Miconazole*,  Ketoconazole,  Terconazole,  Itraconazole,  Fluconazole, Naftifine hydrochloride, Tolnaftate*.</span></h1><h1 style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Anti-protozoal Agents: <span class="p">Metronidazole*, Tinidazole, Ornidazole, Diloxanide, Iodoquinol, Pentamidine Isethionate, Atovaquone, Eflornithine.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Anthelmintics: <span class="p">Diethylcarbamazine citrate*, Thiabendazole, Mebendazole*, Albendazole, Niclosamide, Oxamniquine, Praziquantal, Ivermectin.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Sulphonamides and Sulfones</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Historical development, chemistry, classification and SAR of Sulfonamides: Sulphamethizole,  Sulfisoxazole,  Sulphamethizine,  Sulfacetamide*,  Sulphapyridine, Sulfamethoxaole*, Sulphadiazine, Mefenide acetate, Sulfasalazine.</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Folate reductase inhibitors: <span class="p">Trimethoprim*, Cotrimoxazole.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Sulfones: <span class="p">Dapsone*.</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – V</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Introduction to Drug Design</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Various approaches used in drug design.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Physicochemical parameters used in quantitative structure activity relationship (QSAR) such as partition coefficient, Hammet’s electronic parameter, Tafts steric parameter and Hansch analysis. Pharmacophore modeling and docking techniques.</p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Combinatorial Chemistry:  <span class="p">Concept   and    applications    of combinatorial chemistry: solid phase and solution phase synthesis.</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest Editions)</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Wilson and Giswold’s Organic medicinal and Pharmaceutical Chemistry. Foye’s Principles of Medicinal Chemistry.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Burger’s Medicinal Chemistry, Vol I to IV.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Introduction to principles of drug design- Smith and Williams. Remington’s Pharmaceutical Sciences.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Martindale’s extra pharmacopoeia. Organic Chemistry by I.L. Finar, Vol. II.</p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">The Organic Chemistry of Drug Synthesis by Lednicer, Vol. 1-5.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Indian Pharmacopoeia.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Text book of practical organic chemistry- A.I.Vogel.</p><h1 style="padding-top: 3pt;padding-left: 82pt;text-indent: 0pt;text-align: center;">PY 601: MEDICINAL CHEMISTRY- III (Practical)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">I Preparation of drugs and intermediates</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Sulphanilamide</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">7-Hydroxy, 4-methyl coumarin Chlorobutanol</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Triphenyl imidazole Tolbutamide Hexamine</p><ol id="l1"><li data-list-text="II"><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Assay of drugs <span class="p">Isonicotinic acid hydrazide Chloroquine Metronidazole</span></h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Dapsone Chlorpheniramine maleate Benzyl penicillin</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="III"><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Preparation of medicinally important compounds or intermediates by Microwave irradiation technique</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="IV"><p style="padding-left: 21pt;text-indent: -16pt;text-align: left;">Drawing structures and reactions using chem draw®</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="V"><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Determination of physicochemical properties such as logP, clogP, MR, Molecular weight, Hydrogen bond donors and acceptors for class of drugs course content using drug design software Drug likeliness screening (Lipinskies RO5)</p></li></ol><h1 style="padding-top: 3pt;padding-left: 82pt;text-indent: 0pt;text-align: center;">PY -602 PHARMACOLOGY-III (Theory)</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-I</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Pharmacology of drugs acting on Respiratory system</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Anti -asthmatic drugs</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Drugs used in the management of COPD Expectorants and antitussives</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Nasal decongestants Respiratory stimulants</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Pharmacology of drugs acting on the Gastrointestinal Tract</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Antiulcer agents.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Drugs for constipation and diarrhoea. Appetite stimulants and suppressants. Digestants and carminatives.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Emetics and anti-emetics.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-II</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Chemotherapy</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">General principles of chemotherapy. Sulfonamides and cotrimoxazole.</p><p class="s2" style="padding-left: 5pt;text-indent: 2pt;text-align: left;">Antibiotics- Penicillins, cephalosporins, chloramphenicol, macrolides, quinolones and fluoroquinolins, tetracycline and aminoglycosides</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-III</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Chemotherapy <span class="p">Antitubercular agents Antileprotic agents Antifungal agents Antiviral drugs Anthelmintics Antimalarial drugs Antiamoebic agents</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-IV</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Chemotherapy</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Urinary tract infections and sexually transmitted diseases. Chemotherapy of malignancy.</p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Immunopharmacology <span class="p">Immunostimulants Immunosuppressant</span></h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Protein drugs, monoclonal antibodies, target drugs to antigen, biosimilars</p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-V</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Principles of toxicology</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Definition and basic knowledge of acute, subacute and chronic toxicity.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 110%;text-align: left;">Definition and basic knowledge of genotoxicity, carcinogenicity, teratogenicity and mutagenicity</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">General principles of treatment of poisoning</p><p class="s2" style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 120%;text-align: left;">Clinical symptoms and management of barbiturates, morphine, organophosphosphorus compound and lead, mercury and arsenic poisoning.</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Chronopharmacology</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Definition of rhythm and cycles.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Biological clock and their significance leading to chronotherapy.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest Editions)</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Rang H. P., Dale M. M., Ritter J. M., Flower R. J., Rang and Dale’s Pharmacology, Churchil Livingstone Elsevier</p><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 172%;text-align: left;">Katzung B. G., Masters S. B., Trevor A. J., Basic and clinical pharmacology, Tata Mc Graw-Hill Goodman and Gilman’s, The Pharmacological Basis of Therapeutics</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: justify;">Marry Anne K. K., Lloyd Yee Y., Brian K. A., Robbin L.C., Joseph G. B., Wayne A. K., Bradley R.W., Applied Therapeutics, The Clinical use of Drugs. The Point Lippincott Williams &amp; Wilkins</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Mycek M.J, Gelnet S.B and Perper M.M. Lippincott’s Illustrated Reviews- Pharmacology</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">K.D.Tripathi. Essentials of Medical Pharmacology, , JAYPEE Brothers Medical Publishers</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">(P) Ltd, New Delhi.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Sharma H. L., Sharma K. K., Principles of Pharmacology, Paras medical publisher Modern Pharmacology with clinical Applications, by Charles R.Craig&amp; Robert,</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 172%;text-align: left;">Ghosh MN. Fundamentals of Experimental Pharmacology. Hilton &amp; Company, Kolkata, Kulkarni SK. Handbook of experimental pharmacology. VallabhPrakashan,</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">N.Udupa and P.D. Gupta, Concepts in Chronopharmacology.</p><h1 style="padding-top: 3pt;padding-left: 77pt;text-indent: 0pt;text-align: center;">PY 602 PHARMACOLOGY-III (Practical)</h1><ol id="l2"><li data-list-text="1."><p style="padding-top: 9pt;padding-left: 76pt;text-indent: -53pt;text-align: left;">Dose calculation in pharmacological experiments</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="2."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Antiallergic activity by mast cell stabilization assay</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3."><p style="padding-left: 41pt;text-indent: -18pt;line-height: 110%;text-align: left;">	Study of anti-ulcer activity of a drug using pylorus ligand (SHAY) rat model and NSAIDS induced ulcer model.</p></li><li data-list-text="4."><p style="padding-top: 10pt;padding-left: 76pt;text-indent: -53pt;text-align: left;">Study of effect of drugs on gastrointestinal motility</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Effect of agonist and antagonists on guinea pig ileum</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="6."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Estimation of serum biochemical parameters by using semi- autoanalyser</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="7."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Effect of saline purgative on frog intestine</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="8."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Insulin hypoglycemic effect in rabbit</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="9."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Test for pyrogens ( rabbit method)</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="10."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Determination of acute oral toxicity (LD50) of a drug from a given data</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="11."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Determination of acute skin irritation / corrosion of a test substance</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="12."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Determination of acute eye irritation / corrosion of a test substance</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="13."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Calculation of pharmacokinetic parameters from a given data</p></li><li data-list-text="14."><p style="padding-top: 11pt;padding-left: 76pt;text-indent: -53pt;text-align: left;">Biostatistics methods in experimental pharmacology( student’s t test, ANOVA)</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="15."><p style="padding-left: 41pt;text-indent: -18pt;line-height: 111%;text-align: left;">	Biostatistics methods in experimental pharmacology (Chi square test, Wilcoxon Signed Rank test)</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 41pt;text-indent: 0pt;text-align: left;">*Experiments are demonstrated by simulated experiments/videos</p><h1 style="padding-top: 3pt;padding-left: 92pt;text-indent: 0pt;text-align: left;">PY 603 HERBAL DRUG TECHNOLOGY (Theory)</h1><h2 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-I</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Herbs as raw materials</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Definition of herb, herbal medicine, herbal medicinal product, herbal drug preparation Source of Herbs</p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Selection, identification and authentication of herbal materials Processing of herbal raw material</p><h2 style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Biodynamic Agriculture</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Good agricultural practices in cultivation of medicinal plants including Organic farming. Pest and Pest management in medicinal plants: Biopesticides/Bioinsecticides.</p><h2 style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Indian Systems of Medicine</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Basic principles involved in Ayurveda, Siddha, Unani and Homeopathy Preparation and standardization of Ayurvedic formulations viz Aristas and Asawas, Ghutika,Churna, Lehya and Bhasma.</p><h2 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-II</h2><h2 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Nutraceuticals</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">General aspects, Market, growth, scope and types of products available in the market. Health benefits and role of Nutraceuticals in ailments like Diabetes, CVS diseases, Cancer, Irritable bowel syndrome and various Gastro intestinal diseases.</p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Study of following herbs as health food: Alfaalfa, Chicory, Ginger, Fenugreek, Garlic, Honey, Amla, Ginseng, Ashwagandha, Spirulina</p><h2 style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Herbal-Drug and Herb-Food Interactions: <span class="s2">General introduction to interaction and classification. Study of following drugs and their possible side effects and interactions: Hypercium, kava-kava, Ginkobiloba, Ginseng, Garlic, Pepper &amp; Ephedra.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-III</h2><h2 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Herbal Cosmetics</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Sources and description of raw materials of herbal origin used via, fixed oils, waxes, gums colours, perfumes, protective agents, bleaching agents, antioxidants in products such as skin care, hair care and oral hygiene products.</p><h2 style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Herbal excipients</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Herbal Excipients – Significance of substances of natural origin as excipients – colorants, sweeteners, binders, diluents, viscosity builders, disintegrants, flavors &amp; perfumes.</p><h2 style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Herbal formulations :</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Conventional herbal formulations like syrups, mixtures and tablets and Novel dosage forms like phytosomes</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT- IV</h2><h2 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Evaluation of Drugs <span class="s2">WHO &amp; ICH guidelines for the assessment of herbal drugs Stability testing of herbal drugs.</span></h2><h2 style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Patenting and Regulatory requirements of natural products:</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Definition of the terms: Patent, IPR, Farmers right, Breeder’s right, Bioprospecting and Biopiracy Patenting aspects of Traditional Knowledge and Natural Products. Case study of Curcuma &amp; Neem.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Regulatory Issues <span class="s2">- Regulations in India (ASU DTAB, ASU DCC), Regulation of manufacture of ASU drugs - Schedule Z of Drugs &amp; Cosmetics Act for ASU drugs.</span></h2><h2 style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT - V</h2><h2 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">General Introduction to Herbal Industry</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Herbal drugs industry: Present scope and future prospects.</p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">A brief account of plant based industries and institutions involved in work on medicinal and aromatic plants in India.</p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">S<b>chedule T – Good Manufacturing Practice of Indian systems of medicine</b></p><p class="s2" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Components of GMP (Schedule – T) and its objectives</p><p class="s2" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Infrastructural requirements, working space, storage area, machinery and equipments, standard operating procedures, health and hygiene, documentation and records.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books: (Latest Editions)</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 150%;text-align: left;">Textbook of Pharmacognosy by Trease &amp; Evans. Textbook of Pharmacognosy by Tyler, Brady &amp; Robber. Pharmacognosy by Kokate, Purohit and Gokhale Essential of Pharmacognosy by Dr.S.H.Ansari Pharmacognosy &amp; Phytochemistry by V.D.Rangari</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 146%;text-align: left;">Pharmacopoeal standards for Ayurvedic Formulation (Council of Research in Indian Medicine &amp; Homeopathy)</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 148%;text-align: left;">Mukherjee, P.W. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. Business Horizons Publishers, New Delhi, India, 2002.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 4pt;padding-left: 83pt;text-indent: 0pt;text-align: left;">PY 603 HERBAL DRUG TECHNOLOGY (Practical)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l3"><li data-list-text="1."><p class="s2" style="padding-top: 7pt;padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">To perform preliminary phytochemical screening of crude drugs.</p></li><li data-list-text="2."><p class="s2" style="padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">Determination of the alcohol content of Asava and Arista</p></li><li data-list-text="3."><p class="s2" style="padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">Evaluation of excipients of natural origin</p></li><li data-list-text="4."><p class="s2" style="padding-top: 10pt;padding-left: 41pt;text-indent: -18pt;text-align: left;">	Incorporation of prepared and standardized extract in cosmetic formulations like creams, lotions and shampoos and their evaluation.</p></li><li data-list-text="5."><p class="s2" style="padding-top: 11pt;padding-left: 41pt;text-indent: -18pt;text-align: left;">	Incorporation of prepared and standardized extract in formulations like syrups, mixtures and tablets and their evaluation as per Pharmacopoeial requirements.</p></li><li data-list-text="6."><p class="s2" style="padding-top: 9pt;padding-left: 54pt;text-indent: -31pt;text-align: left;">Monograph analysis of herbal drugs from recent Pharmacopoeias</p></li><li data-list-text="7."><p class="s2" style="padding-top: 10pt;padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">Determination of Aldehyde content</p></li><li data-list-text="8."><p class="s2" style="padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">Determination of Phenol content</p></li><li data-list-text="9."><p class="s2" style="padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">Determination of total alkaloids</p></li></ol><h1 style="padding-top: 3pt;padding-left: 14pt;text-indent: 0pt;text-align: left;">PY 604 BIOPHARMACEUTICS AND PHARMACOKINETICS (Theory)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 4pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">UNIT - I</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Introduction to Biopharmaceutics</h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Absorption<span class="p">; Mechanisms of drug absorption through GIT, factors influencing drug absorption though GIT, absorption of drug from Non per oral extra-vascular routes, </span>Distribution <span class="p">Tissue permeability of drugs, binding of drugs, apparent, volume of drug distribution, plasma and tissue protein binding of drugs, factors affecting protein-drug binding. Kinetics of protein binding, Clinical significance of protein binding of drugs</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- II</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Elimination: <span class="p">Drug metabolism and basic understanding metabolic pathways renal excretion of drugs, factors affecting renal excretion of drugs, renal clearance, Non renal routes of drug excretion of drugs</span></h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: justify;"><b>Bioavailability and Bioequivalence: </b>Definition and Objectives of bioavailability, absolute and relative bioavailability, measurement of bioavailability, <i>in-vitro </i>drug dissolution models, <i>in- vitro</i>-<i>in-vivo </i>correlations, bioequivalence studies, methods to enhance the dissolution rates and bioavailability of poorly soluble drugs.</p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- III</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Pharmacokinetics: <span class="p">Definition and introduction to Pharmacokinetics, Compartment models, Non compartment models, physiological models, One compartment open model. (a).</span></h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Intravenous Injection (Bolus) (b). Intravenous infusion and (c) Extra vascular administrations.</p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Pharmacokinetics parameters - K<span class="s4">E </span>,t1/2,Vd,AUC,Ka, Clt and CL<span class="s4">R</span>- definitions methods of eliminations, understanding of their significance and application</p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- IV</h1><p class="s5" style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Multicompartment models: <span class="p">Two compartment open model. IV bolus</span></p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Kinetics of multiple dosing, steady state drug levels, calculation of loading and mainetnance doses and their significance in clinical settins.</p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- V</h1><h1 style="padding-top: 9pt;padding-left: 8pt;text-indent: -3pt;text-align: left;">Nonlinear Pharmacokinetics: <span class="p">a. Introduction, b. Factors causing Non-linearity. Michaelis-menton method of estimating parameters, Explanation with example of drugs.</span></h1><h1 style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books: (Latest Editions)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Biopharmaceutics and Clinical Pharmacokinetics by, Milo Gibaldi. Biopharmaceutics and Pharmacokinetics; By Robert F Notari</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Applied biopharmaceutics and pharmacokinetics, Leon Shargel and Andrew B.C.YU 4th edition,Prentice-Hall Inernational edition.USA</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Bio pharmaceutics and Pharmacokinetics-A Treatise, By D. M. Brahmankar and Sunil B.Jaiswal,Vallabh Prakashan Pitampura, Delhi</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Pharmacokinetics: By Milo Glbaldi Donald, R. Mercel Dekker Inc.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Hand Book of Clinical Pharmacokinetics, By Milo Gibaldi and Laurie Prescott by ADIS Health Science Press.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Biopharmaceutics; By Swarbrick</p><p class="s2" style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Clinical Pharmacokinetics, Concepts and Applications: By Malcolm Rowland and</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Thomas, N. Tozen, Lea and Febrger, Philadelphia, 1995.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Dissolution, Bioavailability and Bioequivalence, By Abdou H.M, Mack, Publishing Company,Pennsylvania 1989.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Biopharmaceutics and Clinical Pharmacokinetics-An introduction 4th edition Revised and expanded by Rebort F Notari Marcel Dekker Inn, New York and Basel, 1987.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Remington’s Pharmaceutical Sciences, By Mack Publishing Company, Pennsylvnia</p><h1 style="padding-top: 3pt;padding-left: 74pt;text-indent: 0pt;text-align: center;">PY 605 PHARMACEUTICAL BIOTECHNOLOGY (Theory)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 11pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- I</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 144%;text-align: left;">Brief introduction to Biotechnology with reference to Pharmaceutical Sciences. Enzyme Biotechnology- Methods of enzyme immobilization and applications. Biosensors- Working and applications of biosensors in Pharmaceutical Industries. Brief introduction to Protein Engineering.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Use of microbes in industry. Production of Enzymes- General consideration - Amylase, Catalase, Peroxidase, Lipase, Protease, Penicillinase.</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Basic principles of genetic engineering.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- II</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Study of cloning vectors, restriction endonucleases and DNA ligase. Recombinant DNA technology. Application of genetic engineering in medicine. Application of r DNA technology and genetic engineering in the production of: Interferon ii) Vaccines- hepatitis- B iii) Hormones-Insulin.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Brief introduction to PCR</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- III</h1><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 24pt;text-align: left;">Types of immunity- humoral immunity, cellular immunity Structure of Immunoglobulins</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Structure and Function of MHC</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Hypersensitivity reactions, Immune stimulation and Immune suppressions.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">General method of the preparation of bacterial vaccines, toxoids, viral vaccine, antitoxins, serum- immune blood derivatives and other products relative to immunity.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Storage conditions and stability of official vaccines</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Hybridoma technology- Production, Purification and Applications Blood products and Plasma Substituties.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-IV</h1><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Immuno blotting techniques- ELISA, Western blotting, Southern blotting. Genetic organization of Eukaryotes and Prokaryotes</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Microbial genetics including transformation, transduction, conjugation, plasmids and transposons. Introduction to Microbial biotransformation and applications.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Mutation: Types of mutation/mutants.</p><h1 style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-V</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Fermentation methods and general requirements, study of media, equipments, sterilization methods, aeration process, stirring.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Large scale production fermenter design and its various controls.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Study of the production of - penicillins, citric acid, Vitamin B12, Glutamic acid, Griseofulvin, Blood Products: Collection, Processing and Storage of whole human blood, dried human plasma, plasma Substituties.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest edition):</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">B.R. Glick and J.J. Pasternak: Molecular Biotechnology: Principles and Applications of RecombinantDNA: ASM Press Washington D.C.</p><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">RA Goldshy et. al., : Kuby Immunology.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">J.W. Goding: Monoclonal Antibodies.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">J.M. Walker and E.B. Gingold: Molecular Biology and Biotechnology by Royal Society of Chemistry.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Zaborsky: Immobilized Enzymes, CRC Press, Degraland, Ohio.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">S.B. Primrose: Molecular Biotechnology (Second Edition) Blackwell Scientific Publication.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Stanbury F., P., Whitakar A., and Hall J., S., Principles of fermentation technology, 2nd edition, Aditya books Ltd., New Delhi</p><h1 style="padding-top: 3pt;padding-left: 85pt;text-indent: 0pt;text-align: center;">PY 606 PHARMACEUTICAL QUALITY ASSURANCE (Theory)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – I</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Quality Assurance and Quality Management concepts: <span class="p">Definition and concept of Qualitycontrol, Quality assurance and GMP</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Total Quality Management (TQM): <span class="p">Definition, elements, philosophies</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: left;">ICH Guidelines<span class="p">: purpose, participants, process of harmonization, Brief overview of QSEM, with special emphasis on Q-series guidelines, ICH stability testing guidelines</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 107%;text-align: left;">Quality by design (QbD)<span class="p">: Definition, overview, elements of QbD program, tools </span>ISO 9000 &amp; ISO14000<span class="p">: Overview, Benefits, Elements, steps for registration </span>NABL accreditation <span class="p">: Principles and procedures</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT -II</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Organization and personnel: <span class="p">Personnel responsibilities, training, hygiene and personal records. </span>Premises: <span class="p">Design, construction and plant layout, maintenance, sanitation, environmental control, utilities and maintenance of sterile areas, control of contamination.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Equipments and raw materials: <span class="p">Equipment selection, purchase specifications, maintenance, purchase specifications and maintenance of stores for raw materials.</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – III</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 107%;text-align: left;">Quality Control: <span class="p">Quality control test for containers, rubber closures and secondary packing materials. </span>Good Laboratory Practices: <span class="p">General Provisions, Organization and Personnel, Facilities, Equipment, Testing Facilities Operation, Test and Control Articles, Protocol for Conduct of a Nonclinical</span></h1><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Laboratory Study, Records and Reports, Disqualification of Testing Facilities</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – IV</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: left;">Complaints: <span class="p">Complaints and evaluation of complaints, Handling of return good, recalling and waste disposal.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: left;">Document maintenance in pharmaceutical industry: <span class="p">Batch Formula Record, Master Formula Record, SOP, Quality audit, Quality Review and Quality documentation, Reports and documents, distribution records.</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – V</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Calibration  and  Validation:  <span class="p">Introduction,  definition  and  general  principles  of  calibration, qualification and validation, importance and scope of validation, types of validation, validation master plan. Calibration of pH meter, Qualification of UV-Visible spectrophotometer, General principles of Analytical method Validation.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Warehousing: <span class="p">Good warehousing practice, materials management</span></h1><h1 style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books: (Latest Edition)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 76%;text-align: left;">Quality Assurance Guide by organization of Pharmaceutical Products of India. Good Laboratory Practice Regulations, 2<span class="s6">nd </span>Edition, Sandy Weinberg Vol. 69.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: left;">Quality Assurance of Pharmaceuticals- A compendium of Guide lines and Related materials Vol I WHO Publications.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">A guide to Total Quality Management- Kushik Maitra and Sedhan K Ghosh How to Practice GMP’s – P P Sharma.</p><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">ISO 9000 and Total Quality Management – Sadhank G Ghosh</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">The International Pharmacopoeia – Vol I, II, III, IV- General Methods of Analysis and Quality specification for Pharmaceutical Substances, Excipients and Dosage forms</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Good laboratory Practices – Marcel Deckker Series ICH guidelines, ISO 9000 and 14000 guidelines</p></body></html>
=======
<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>Microsoft Word - B.Pharm VI Sem _Syllabus_ as per PCI Regulation</title><meta name="author" content="hp"/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 h1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; margin:0pt; }
 .s1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 12pt; }
 h2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 11.5pt; }
 .s4 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10.5pt; vertical-align: -2pt; }
 .s5 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: bold; text-decoration: none; font-size: 12pt; }
 .s6 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10.5pt; vertical-align: 7pt; }
 li {display: block; }
 #l1 {padding-left: 0pt;counter-reset: c1 2; }
 #l1> li>*:first-child:before {counter-increment: c1; content: counter(c1, upper-roman)" "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; }
 #l1> li:first-child>*:first-child:before {counter-increment: c1 0;  }
 li {display: block; }
 #l2 {padding-left: 0pt;counter-reset: d1 1; }
 #l2> li>*:first-child:before {counter-increment: d1; content: counter(d1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; }
 #l2> li:first-child>*:first-child:before {counter-increment: d1 0;  }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: e1 1; }
 #l3> li>*:first-child:before {counter-increment: e1; content: counter(e1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11.5pt; }
 #l3> li:first-child>*:first-child:before {counter-increment: e1 0;  }
</style></head><body><h1 style="padding-top: 3pt;padding-left: 85pt;text-indent: 0pt;text-align: center;">PY-601 . MEDICINAL CHEMISTRY – III (Theory)</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: justify;">Study of the development of the following classes of drugs, Classification, mechanism of action, uses of drugs mentioned in the course, Structure activity relationship of selective class of drugs as specified in the course and synthesis of drugs superscripted by (*)</p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – I</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Antibiotics</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Historical background, Nomenclature, Stereochemistry, Structure activity relationship, Chemical degradation classification and important products of the following classes :</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">β-Lactam antibiotics: <span class="p">Penicillin, Cepholosporins, β- Lactamase inhibitors, Monobactams</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Aminoglycosides: <span class="p">Streptomycin, Neomycin, Kanamycin</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Tetracyclines: <span class="p">Tetracycline,Oxytetracycline, Chlortetracycline, Minocycline, Doxycycline</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – II</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Antibiotics</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Historical background, Nomenclature, Stereochemistry, Structure activity relationship, Chemical degradation classification and important products of the following classes: <b>Macrolide: </b>Erythromycin Clarithromycin, Azithromycin.</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Miscellaneous: <span class="p">Chloramphenicol*, Clindamycin.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Prodrugs: <span class="p">Basic concepts and application of prodrugs design.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Antimalarials: <span class="p">Etiology of malaria.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Quinolines: <span class="p">SAR, Quinine sulphate, Chloroquine*, Amodiaquine, Primaquine phosphate, Pamaquine*, Quinacrine hydrochloride, Mefloquine.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Biguanides and dihydro triazines: <span class="p">Cycloguanil pamoate, Proguanil.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Miscellaneous: <span class="p">Pyrimethamine, Artesunete, Artemether, Atovoquone.</span></h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – III</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Anti-tubercular Agents</h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Synthetic anti tubercular agents: <span class="p">Isoniozid*, Ethionamide, Ethambutol, Pyrazinamide, Para amino salicylic acid.*</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Anti tubercular antibiotics: <span class="p">Rifampicin, Rifabutin, Cycloserine Streptomycine, Capreomycin sulphate.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Urinary tract anti-infective agents</h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Quinolones:<span class="p">SAR     of   quinolones,   Nalidixic Acid,Norfloxacin, </span><span class="s1">Enoxacin,</span></h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Ciprofloxacin*, Ofloxacin, Lomefloxacin, Sparfloxacin, Gatifloxacin, Moxifloxacin</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Miscellaneous: Furazolidine, Nitrofurantoin*, Methanamine.</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Antiviral agents:</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Amantadine hydrochloride, Rimantadine hydrochloride, Idoxuridine trifluoride, Acyclovir*, Gancyclovir, Zidovudine, Didanosine, Zalcitabine, Lamivudine, Loviride, Delavirding, Ribavirin, Saquinavir, Indinavir, Ritonavir.</p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – IV</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Antifungal agents:</h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Antifungal antibiotics: <span class="p">Amphotericin-B, Nystatin, Natamycin, Griseofulvin.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Synthetic Antifungal agents: <span class="p">Clotrimazole, Econazole, Butoconazole, Oxiconazole Tioconozole,  Miconazole*,  Ketoconazole,  Terconazole,  Itraconazole,  Fluconazole, Naftifine hydrochloride, Tolnaftate*.</span></h1><h1 style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Anti-protozoal Agents: <span class="p">Metronidazole*, Tinidazole, Ornidazole, Diloxanide, Iodoquinol, Pentamidine Isethionate, Atovaquone, Eflornithine.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Anthelmintics: <span class="p">Diethylcarbamazine citrate*, Thiabendazole, Mebendazole*, Albendazole, Niclosamide, Oxamniquine, Praziquantal, Ivermectin.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Sulphonamides and Sulfones</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Historical development, chemistry, classification and SAR of Sulfonamides: Sulphamethizole,  Sulfisoxazole,  Sulphamethizine,  Sulfacetamide*,  Sulphapyridine, Sulfamethoxaole*, Sulphadiazine, Mefenide acetate, Sulfasalazine.</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Folate reductase inhibitors: <span class="p">Trimethoprim*, Cotrimoxazole.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Sulfones: <span class="p">Dapsone*.</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – V</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Introduction to Drug Design</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Various approaches used in drug design.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Physicochemical parameters used in quantitative structure activity relationship (QSAR) such as partition coefficient, Hammet’s electronic parameter, Tafts steric parameter and Hansch analysis. Pharmacophore modeling and docking techniques.</p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Combinatorial Chemistry:  <span class="p">Concept   and    applications    of combinatorial chemistry: solid phase and solution phase synthesis.</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest Editions)</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Wilson and Giswold’s Organic medicinal and Pharmaceutical Chemistry. Foye’s Principles of Medicinal Chemistry.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Burger’s Medicinal Chemistry, Vol I to IV.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Introduction to principles of drug design- Smith and Williams. Remington’s Pharmaceutical Sciences.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Martindale’s extra pharmacopoeia. Organic Chemistry by I.L. Finar, Vol. II.</p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">The Organic Chemistry of Drug Synthesis by Lednicer, Vol. 1-5.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Indian Pharmacopoeia.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Text book of practical organic chemistry- A.I.Vogel.</p><h1 style="padding-top: 3pt;padding-left: 82pt;text-indent: 0pt;text-align: center;">PY 601: MEDICINAL CHEMISTRY- III (Practical)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">I Preparation of drugs and intermediates</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Sulphanilamide</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">7-Hydroxy, 4-methyl coumarin Chlorobutanol</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Triphenyl imidazole Tolbutamide Hexamine</p><ol id="l1"><li data-list-text="II"><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Assay of drugs <span class="p">Isonicotinic acid hydrazide Chloroquine Metronidazole</span></h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Dapsone Chlorpheniramine maleate Benzyl penicillin</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="III"><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Preparation of medicinally important compounds or intermediates by Microwave irradiation technique</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="IV"><p style="padding-left: 21pt;text-indent: -16pt;text-align: left;">Drawing structures and reactions using chem draw®</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="V"><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Determination of physicochemical properties such as logP, clogP, MR, Molecular weight, Hydrogen bond donors and acceptors for class of drugs course content using drug design software Drug likeliness screening (Lipinskies RO5)</p></li></ol><h1 style="padding-top: 3pt;padding-left: 82pt;text-indent: 0pt;text-align: center;">PY -602 PHARMACOLOGY-III (Theory)</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-I</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Pharmacology of drugs acting on Respiratory system</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Anti -asthmatic drugs</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Drugs used in the management of COPD Expectorants and antitussives</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Nasal decongestants Respiratory stimulants</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Pharmacology of drugs acting on the Gastrointestinal Tract</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Antiulcer agents.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Drugs for constipation and diarrhoea. Appetite stimulants and suppressants. Digestants and carminatives.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Emetics and anti-emetics.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-II</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Chemotherapy</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">General principles of chemotherapy. Sulfonamides and cotrimoxazole.</p><p class="s2" style="padding-left: 5pt;text-indent: 2pt;text-align: left;">Antibiotics- Penicillins, cephalosporins, chloramphenicol, macrolides, quinolones and fluoroquinolins, tetracycline and aminoglycosides</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-III</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Chemotherapy <span class="p">Antitubercular agents Antileprotic agents Antifungal agents Antiviral drugs Anthelmintics Antimalarial drugs Antiamoebic agents</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-IV</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Chemotherapy</h1><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Urinary tract infections and sexually transmitted diseases. Chemotherapy of malignancy.</p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Immunopharmacology <span class="p">Immunostimulants Immunosuppressant</span></h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Protein drugs, monoclonal antibodies, target drugs to antigen, biosimilars</p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-V</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Principles of toxicology</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Definition and basic knowledge of acute, subacute and chronic toxicity.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 110%;text-align: left;">Definition and basic knowledge of genotoxicity, carcinogenicity, teratogenicity and mutagenicity</p><p style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">General principles of treatment of poisoning</p><p class="s2" style="padding-top: 2pt;padding-left: 5pt;text-indent: 0pt;line-height: 120%;text-align: left;">Clinical symptoms and management of barbiturates, morphine, organophosphosphorus compound and lead, mercury and arsenic poisoning.</p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Chronopharmacology</h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Definition of rhythm and cycles.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Biological clock and their significance leading to chronotherapy.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest Editions)</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Rang H. P., Dale M. M., Ritter J. M., Flower R. J., Rang and Dale’s Pharmacology, Churchil Livingstone Elsevier</p><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 172%;text-align: left;">Katzung B. G., Masters S. B., Trevor A. J., Basic and clinical pharmacology, Tata Mc Graw-Hill Goodman and Gilman’s, The Pharmacological Basis of Therapeutics</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: justify;">Marry Anne K. K., Lloyd Yee Y., Brian K. A., Robbin L.C., Joseph G. B., Wayne A. K., Bradley R.W., Applied Therapeutics, The Clinical use of Drugs. The Point Lippincott Williams &amp; Wilkins</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Mycek M.J, Gelnet S.B and Perper M.M. Lippincott’s Illustrated Reviews- Pharmacology</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">K.D.Tripathi. Essentials of Medical Pharmacology, , JAYPEE Brothers Medical Publishers</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">(P) Ltd, New Delhi.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Sharma H. L., Sharma K. K., Principles of Pharmacology, Paras medical publisher Modern Pharmacology with clinical Applications, by Charles R.Craig&amp; Robert,</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 172%;text-align: left;">Ghosh MN. Fundamentals of Experimental Pharmacology. Hilton &amp; Company, Kolkata, Kulkarni SK. Handbook of experimental pharmacology. VallabhPrakashan,</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">N.Udupa and P.D. Gupta, Concepts in Chronopharmacology.</p><h1 style="padding-top: 3pt;padding-left: 77pt;text-indent: 0pt;text-align: center;">PY 602 PHARMACOLOGY-III (Practical)</h1><ol id="l2"><li data-list-text="1."><p style="padding-top: 9pt;padding-left: 76pt;text-indent: -53pt;text-align: left;">Dose calculation in pharmacological experiments</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="2."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Antiallergic activity by mast cell stabilization assay</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="3."><p style="padding-left: 41pt;text-indent: -18pt;line-height: 110%;text-align: left;">	Study of anti-ulcer activity of a drug using pylorus ligand (SHAY) rat model and NSAIDS induced ulcer model.</p></li><li data-list-text="4."><p style="padding-top: 10pt;padding-left: 76pt;text-indent: -53pt;text-align: left;">Study of effect of drugs on gastrointestinal motility</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="5."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Effect of agonist and antagonists on guinea pig ileum</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="6."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Estimation of serum biochemical parameters by using semi- autoanalyser</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="7."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Effect of saline purgative on frog intestine</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="8."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Insulin hypoglycemic effect in rabbit</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="9."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Test for pyrogens ( rabbit method)</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="10."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Determination of acute oral toxicity (LD50) of a drug from a given data</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="11."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Determination of acute skin irritation / corrosion of a test substance</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="12."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Determination of acute eye irritation / corrosion of a test substance</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="13."><p style="padding-left: 76pt;text-indent: -53pt;text-align: left;">Calculation of pharmacokinetic parameters from a given data</p></li><li data-list-text="14."><p style="padding-top: 11pt;padding-left: 76pt;text-indent: -53pt;text-align: left;">Biostatistics methods in experimental pharmacology( student’s t test, ANOVA)</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li data-list-text="15."><p style="padding-left: 41pt;text-indent: -18pt;line-height: 111%;text-align: left;">	Biostatistics methods in experimental pharmacology (Chi square test, Wilcoxon Signed Rank test)</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 41pt;text-indent: 0pt;text-align: left;">*Experiments are demonstrated by simulated experiments/videos</p><h1 style="padding-top: 3pt;padding-left: 92pt;text-indent: 0pt;text-align: left;">PY 603 HERBAL DRUG TECHNOLOGY (Theory)</h1><h2 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-I</h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Herbs as raw materials</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Definition of herb, herbal medicine, herbal medicinal product, herbal drug preparation Source of Herbs</p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Selection, identification and authentication of herbal materials Processing of herbal raw material</p><h2 style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Biodynamic Agriculture</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Good agricultural practices in cultivation of medicinal plants including Organic farming. Pest and Pest management in medicinal plants: Biopesticides/Bioinsecticides.</p><h2 style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Indian Systems of Medicine</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Basic principles involved in Ayurveda, Siddha, Unani and Homeopathy Preparation and standardization of Ayurvedic formulations viz Aristas and Asawas, Ghutika,Churna, Lehya and Bhasma.</p><h2 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-II</h2><h2 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Nutraceuticals</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">General aspects, Market, growth, scope and types of products available in the market. Health benefits and role of Nutraceuticals in ailments like Diabetes, CVS diseases, Cancer, Irritable bowel syndrome and various Gastro intestinal diseases.</p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Study of following herbs as health food: Alfaalfa, Chicory, Ginger, Fenugreek, Garlic, Honey, Amla, Ginseng, Ashwagandha, Spirulina</p><h2 style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Herbal-Drug and Herb-Food Interactions: <span class="s2">General introduction to interaction and classification. Study of following drugs and their possible side effects and interactions: Hypercium, kava-kava, Ginkobiloba, Ginseng, Garlic, Pepper &amp; Ephedra.</span></h2><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-III</h2><h2 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Herbal Cosmetics</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Sources and description of raw materials of herbal origin used via, fixed oils, waxes, gums colours, perfumes, protective agents, bleaching agents, antioxidants in products such as skin care, hair care and oral hygiene products.</p><h2 style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Herbal excipients</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Herbal Excipients – Significance of substances of natural origin as excipients – colorants, sweeteners, binders, diluents, viscosity builders, disintegrants, flavors &amp; perfumes.</p><h2 style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: justify;">Herbal formulations :</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Conventional herbal formulations like syrups, mixtures and tablets and Novel dosage forms like phytosomes</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">UNIT- IV</h2><h2 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Evaluation of Drugs <span class="s2">WHO &amp; ICH guidelines for the assessment of herbal drugs Stability testing of herbal drugs.</span></h2><h2 style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Patenting and Regulatory requirements of natural products:</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Definition of the terms: Patent, IPR, Farmers right, Breeder’s right, Bioprospecting and Biopiracy Patenting aspects of Traditional Knowledge and Natural Products. Case study of Curcuma &amp; Neem.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h2 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Regulatory Issues <span class="s2">- Regulations in India (ASU DTAB, ASU DCC), Regulation of manufacture of ASU drugs - Schedule Z of Drugs &amp; Cosmetics Act for ASU drugs.</span></h2><h2 style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT - V</h2><h2 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">General Introduction to Herbal Industry</h2><p class="s2" style="padding-left: 5pt;text-indent: 0pt;line-height: 13pt;text-align: left;">Herbal drugs industry: Present scope and future prospects.</p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">A brief account of plant based industries and institutions involved in work on medicinal and aromatic plants in India.</p><p class="s2" style="padding-left: 5pt;text-indent: 0pt;text-align: left;">S<b>chedule T – Good Manufacturing Practice of Indian systems of medicine</b></p><p class="s2" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Components of GMP (Schedule – T) and its objectives</p><p class="s2" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Infrastructural requirements, working space, storage area, machinery and equipments, standard operating procedures, health and hygiene, documentation and records.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books: (Latest Editions)</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 150%;text-align: left;">Textbook of Pharmacognosy by Trease &amp; Evans. Textbook of Pharmacognosy by Tyler, Brady &amp; Robber. Pharmacognosy by Kokate, Purohit and Gokhale Essential of Pharmacognosy by Dr.S.H.Ansari Pharmacognosy &amp; Phytochemistry by V.D.Rangari</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 146%;text-align: left;">Pharmacopoeal standards for Ayurvedic Formulation (Council of Research in Indian Medicine &amp; Homeopathy)</p><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 148%;text-align: left;">Mukherjee, P.W. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. Business Horizons Publishers, New Delhi, India, 2002.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 4pt;padding-left: 83pt;text-indent: 0pt;text-align: left;">PY 603 HERBAL DRUG TECHNOLOGY (Practical)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l3"><li data-list-text="1."><p class="s2" style="padding-top: 7pt;padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">To perform preliminary phytochemical screening of crude drugs.</p></li><li data-list-text="2."><p class="s2" style="padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">Determination of the alcohol content of Asava and Arista</p></li><li data-list-text="3."><p class="s2" style="padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">Evaluation of excipients of natural origin</p></li><li data-list-text="4."><p class="s2" style="padding-top: 10pt;padding-left: 41pt;text-indent: -18pt;text-align: left;">	Incorporation of prepared and standardized extract in cosmetic formulations like creams, lotions and shampoos and their evaluation.</p></li><li data-list-text="5."><p class="s2" style="padding-top: 11pt;padding-left: 41pt;text-indent: -18pt;text-align: left;">	Incorporation of prepared and standardized extract in formulations like syrups, mixtures and tablets and their evaluation as per Pharmacopoeial requirements.</p></li><li data-list-text="6."><p class="s2" style="padding-top: 9pt;padding-left: 54pt;text-indent: -31pt;text-align: left;">Monograph analysis of herbal drugs from recent Pharmacopoeias</p></li><li data-list-text="7."><p class="s2" style="padding-top: 10pt;padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">Determination of Aldehyde content</p></li><li data-list-text="8."><p class="s2" style="padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">Determination of Phenol content</p></li><li data-list-text="9."><p class="s2" style="padding-left: 54pt;text-indent: -31pt;line-height: 13pt;text-align: left;">Determination of total alkaloids</p></li></ol><h1 style="padding-top: 3pt;padding-left: 14pt;text-indent: 0pt;text-align: left;">PY 604 BIOPHARMACEUTICS AND PHARMACOKINETICS (Theory)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 4pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">UNIT - I</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: justify;">Introduction to Biopharmaceutics</h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Absorption<span class="p">; Mechanisms of drug absorption through GIT, factors influencing drug absorption though GIT, absorption of drug from Non per oral extra-vascular routes, </span>Distribution <span class="p">Tissue permeability of drugs, binding of drugs, apparent, volume of drug distribution, plasma and tissue protein binding of drugs, factors affecting protein-drug binding. Kinetics of protein binding, Clinical significance of protein binding of drugs</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- II</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 113%;text-align: justify;">Elimination: <span class="p">Drug metabolism and basic understanding metabolic pathways renal excretion of drugs, factors affecting renal excretion of drugs, renal clearance, Non renal routes of drug excretion of drugs</span></h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: justify;"><b>Bioavailability and Bioequivalence: </b>Definition and Objectives of bioavailability, absolute and relative bioavailability, measurement of bioavailability, <i>in-vitro </i>drug dissolution models, <i>in- vitro</i>-<i>in-vivo </i>correlations, bioequivalence studies, methods to enhance the dissolution rates and bioavailability of poorly soluble drugs.</p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- III</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Pharmacokinetics: <span class="p">Definition and introduction to Pharmacokinetics, Compartment models, Non compartment models, physiological models, One compartment open model. (a).</span></h1><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Intravenous Injection (Bolus) (b). Intravenous infusion and (c) Extra vascular administrations.</p><p style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Pharmacokinetics parameters - K<span class="s4">E </span>,t1/2,Vd,AUC,Ka, Clt and CL<span class="s4">R</span>- definitions methods of eliminations, understanding of their significance and application</p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- IV</h1><p class="s5" style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Multicompartment models: <span class="p">Two compartment open model. IV bolus</span></p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Kinetics of multiple dosing, steady state drug levels, calculation of loading and mainetnance doses and their significance in clinical settins.</p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- V</h1><h1 style="padding-top: 9pt;padding-left: 8pt;text-indent: -3pt;text-align: left;">Nonlinear Pharmacokinetics: <span class="p">a. Introduction, b. Factors causing Non-linearity. Michaelis-menton method of estimating parameters, Explanation with example of drugs.</span></h1><h1 style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books: (Latest Editions)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Biopharmaceutics and Clinical Pharmacokinetics by, Milo Gibaldi. Biopharmaceutics and Pharmacokinetics; By Robert F Notari</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Applied biopharmaceutics and pharmacokinetics, Leon Shargel and Andrew B.C.YU 4th edition,Prentice-Hall Inernational edition.USA</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Bio pharmaceutics and Pharmacokinetics-A Treatise, By D. M. Brahmankar and Sunil B.Jaiswal,Vallabh Prakashan Pitampura, Delhi</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Pharmacokinetics: By Milo Glbaldi Donald, R. Mercel Dekker Inc.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Hand Book of Clinical Pharmacokinetics, By Milo Gibaldi and Laurie Prescott by ADIS Health Science Press.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Biopharmaceutics; By Swarbrick</p><p class="s2" style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Clinical Pharmacokinetics, Concepts and Applications: By Malcolm Rowland and</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Thomas, N. Tozen, Lea and Febrger, Philadelphia, 1995.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Dissolution, Bioavailability and Bioequivalence, By Abdou H.M, Mack, Publishing Company,Pennsylvania 1989.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Biopharmaceutics and Clinical Pharmacokinetics-An introduction 4th edition Revised and expanded by Rebort F Notari Marcel Dekker Inn, New York and Basel, 1987.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Remington’s Pharmaceutical Sciences, By Mack Publishing Company, Pennsylvnia</p><h1 style="padding-top: 3pt;padding-left: 74pt;text-indent: 0pt;text-align: center;">PY 605 PHARMACEUTICAL BIOTECHNOLOGY (Theory)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 11pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- I</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 144%;text-align: left;">Brief introduction to Biotechnology with reference to Pharmaceutical Sciences. Enzyme Biotechnology- Methods of enzyme immobilization and applications. Biosensors- Working and applications of biosensors in Pharmaceutical Industries. Brief introduction to Protein Engineering.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Use of microbes in industry. Production of Enzymes- General consideration - Amylase, Catalase, Peroxidase, Lipase, Protease, Penicillinase.</p><p style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Basic principles of genetic engineering.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- II</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Study of cloning vectors, restriction endonucleases and DNA ligase. Recombinant DNA technology. Application of genetic engineering in medicine. Application of r DNA technology and genetic engineering in the production of: Interferon ii) Vaccines- hepatitis- B iii) Hormones-Insulin.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Brief introduction to PCR</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT- III</h1><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 24pt;text-align: left;">Types of immunity- humoral immunity, cellular immunity Structure of Immunoglobulins</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 12pt;text-align: left;">Structure and Function of MHC</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Hypersensitivity reactions, Immune stimulation and Immune suppressions.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">General method of the preparation of bacterial vaccines, toxoids, viral vaccine, antitoxins, serum- immune blood derivatives and other products relative to immunity.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Storage conditions and stability of official vaccines</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Hybridoma technology- Production, Purification and Applications Blood products and Plasma Substituties.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 7pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-IV</h1><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Immuno blotting techniques- ELISA, Western blotting, Southern blotting. Genetic organization of Eukaryotes and Prokaryotes</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Microbial genetics including transformation, transduction, conjugation, plasmids and transposons. Introduction to Microbial biotransformation and applications.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Mutation: Types of mutation/mutants.</p><h1 style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT-V</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Fermentation methods and general requirements, study of media, equipments, sterilization methods, aeration process, stirring.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Large scale production fermenter design and its various controls.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Study of the production of - penicillins, citric acid, Vitamin B12, Glutamic acid, Griseofulvin, Blood Products: Collection, Processing and Storage of whole human blood, dried human plasma, plasma Substituties.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books (Latest edition):</h1><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">B.R. Glick and J.J. Pasternak: Molecular Biotechnology: Principles and Applications of RecombinantDNA: ASM Press Washington D.C.</p><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">RA Goldshy et. al., : Kuby Immunology.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">J.W. Goding: Monoclonal Antibodies.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">J.M. Walker and E.B. Gingold: Molecular Biology and Biotechnology by Royal Society of Chemistry.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Zaborsky: Immobilized Enzymes, CRC Press, Degraland, Ohio.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">S.B. Primrose: Molecular Biotechnology (Second Edition) Blackwell Scientific Publication.</p><p style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Stanbury F., P., Whitakar A., and Hall J., S., Principles of fermentation technology, 2nd edition, Aditya books Ltd., New Delhi</p><h1 style="padding-top: 3pt;padding-left: 85pt;text-indent: 0pt;text-align: center;">PY 606 PHARMACEUTICAL QUALITY ASSURANCE (Theory)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – I</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Quality Assurance and Quality Management concepts: <span class="p">Definition and concept of Qualitycontrol, Quality assurance and GMP</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">Total Quality Management (TQM): <span class="p">Definition, elements, philosophies</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: left;">ICH Guidelines<span class="p">: purpose, participants, process of harmonization, Brief overview of QSEM, with special emphasis on Q-series guidelines, ICH stability testing guidelines</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 107%;text-align: left;">Quality by design (QbD)<span class="p">: Definition, overview, elements of QbD program, tools </span>ISO 9000 &amp; ISO14000<span class="p">: Overview, Benefits, Elements, steps for registration </span>NABL accreditation <span class="p">: Principles and procedures</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT -II</h1><h1 style="padding-top: 10pt;padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Organization and personnel: <span class="p">Personnel responsibilities, training, hygiene and personal records. </span>Premises: <span class="p">Design, construction and plant layout, maintenance, sanitation, environmental control, utilities and maintenance of sterile areas, control of contamination.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Equipments and raw materials: <span class="p">Equipment selection, purchase specifications, maintenance, purchase specifications and maintenance of stores for raw materials.</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-top: 8pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – III</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 107%;text-align: left;">Quality Control: <span class="p">Quality control test for containers, rubber closures and secondary packing materials. </span>Good Laboratory Practices: <span class="p">General Provisions, Organization and Personnel, Facilities, Equipment, Testing Facilities Operation, Test and Control Articles, Protocol for Conduct of a Nonclinical</span></h1><p style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Laboratory Study, Records and Reports, Disqualification of Testing Facilities</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – IV</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: left;">Complaints: <span class="p">Complaints and evaluation of complaints, Handling of return good, recalling and waste disposal.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;line-height: 114%;text-align: left;">Document maintenance in pharmaceutical industry: <span class="p">Batch Formula Record, Master Formula Record, SOP, Quality audit, Quality Review and Quality documentation, Reports and documents, distribution records.</span></h1><p style="text-indent: 0pt;text-align: left;"><br/></p><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: left;">UNIT – V</h1><h1 style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 112%;text-align: justify;">Calibration  and  Validation:  <span class="p">Introduction,  definition  and  general  principles  of  calibration, qualification and validation, importance and scope of validation, types of validation, validation master plan. Calibration of pH meter, Qualification of UV-Visible spectrophotometer, General principles of Analytical method Validation.</span></h1><h1 style="padding-left: 5pt;text-indent: 0pt;text-align: justify;">Warehousing: <span class="p">Good warehousing practice, materials management</span></h1><h1 style="padding-top: 3pt;padding-left: 5pt;text-indent: 0pt;text-align: left;">Recommended Books: (Latest Edition)</h1><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 76%;text-align: left;">Quality Assurance Guide by organization of Pharmaceutical Products of India. Good Laboratory Practice Regulations, 2<span class="s6">nd </span>Edition, Sandy Weinberg Vol. 69.</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 94%;text-align: left;">Quality Assurance of Pharmaceuticals- A compendium of Guide lines and Related materials Vol I WHO Publications.</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">A guide to Total Quality Management- Kushik Maitra and Sedhan K Ghosh How to Practice GMP’s – P P Sharma.</p><p style="padding-top: 9pt;padding-left: 5pt;text-indent: 0pt;line-height: 14pt;text-align: left;">ISO 9000 and Total Quality Management – Sadhank G Ghosh</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">The International Pharmacopoeia – Vol I, II, III, IV- General Methods of Analysis and Quality specification for Pharmaceutical Substances, Excipients and Dosage forms</p><p style="padding-left: 5pt;text-indent: 0pt;text-align: left;">Good laboratory Practices – Marcel Deckker Series ICH guidelines, ISO 9000 and 14000 guidelines</p></body></html>
>>>>>>> html
